Back to Search
YA TZE TONG, M.D.
M.D.
Internal Medicine Physician
NPI: 1245298157IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
77476(MA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 1981
Research & Publications (20)
R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice.
PMID 19667187·Proc Natl Acad Sci U S A·2009
7-preclinical
Analgesic activity of myricetin isolated from Myrica rubra Sieb. et Zucc. leaves.
PMID 19407970·Arch Pharm Res·2009
7-preclinical
Bacterial heme-transport proteins and their heme-coordination modes.
PMID 18977196·Arch Biochem Biophys·2009
6-review
Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modeling.
PMID 18790640·Bioorg Med Chem Lett·2008
8-other
Development of isothermal TaqMan assays for detection of biothreat organisms.
PMID 19007339·Biotechniques·2008
8-other
Variant FCGR3 genes: transcription and possible origins.
PMID 19317341·Asian Pac J Allergy Immunol·2008
8-other
Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors.
PMID 17287122·Bioorg Med Chem·2007
8-other
Cloning and characterization of a novel periplasmic heme-transport protein from the human pathogen Pseudomonas aeruginosa.
PMID 17387526·J Biol Inorg Chem·2007
8-other
Comparisons of urodynamic findings and voiding habits in patients with concomitant benign prostatic hyperplasia and detrusor overactivity presenting with or without the symptom of urgency.
PMID 17406130·Urol Int·2007
4-observational
1,4-Dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: extended exploration on phenyl ring substitutions and preliminary ADME/PK studies.
PMID 17490879·Bioorg Med Chem Lett·2007
7-preclinical
Alterations of M2,3-muscarinic receptor protein and mRNA expression in the bladder of the fructose fed obese rat.
PMID 17707055·J Urol·2007
7-preclinical
Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: improving oral biovailability.
PMID 17768051·Bioorg Med Chem Lett·2007
7-preclinical
Aldose reductase inhibitor ONO-2235 restores the alterations of bladder nerve growth factor and neurotrophin receptor p75 genetic expression in streptozotocin induced diabetic rats.
PMID 17870109·J Urol·2007
7-preclinical
Overexpression of midkine contributes to anti-apoptotic effects in human meningiomas.
PMID 17181554·J Neurochem·2007
4-observational
The high incidence of varicella herpes zoster with the use of bortezomib in 10 patients.
PMID 17133426·Am J Hematol·2007
8-other
Eye drop delivery of nano-polymeric micelle formulated genes with cornea-specific promoters.
PMID 17724775·J Gene Med·2007
7-preclinical
Growth and optical properties of faceted hexagonal ZnO nanotubes.
PMID 16869578·J Phys Chem B·2006
8-other
Alteration of fexofenadine disposition in the rat isolated perfused liver following injection of bacterial lipopolysaccharide.
PMID 16895540·Clin Exp Pharmacol Physiol·2006
4-observational
Alterations of M(2)-muscarinic receptor protein and mRNA expression in the urothelium and muscle layer of the streptozotocin-induced diabetic rat urinary bladder.
PMID 16935418·Neurosci Lett·2006
4-observational
Growth of ZnO nanostructures with different morphologies by using hydrothermal technique.
PMID 17034205·J Phys Chem B·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 86 BAKER AVENUE EXT
CONCORD, MA 01742 - Phone
- (978) 287-9310
Quick Facts
- NPI
- 1245298157
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 45
- Publications
- 20
Are you this provider?
Claim Your Profile